Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 478

The DOI matches its Crossref record; 337 of the 337 references it cites were found in a registry or an index.

Neuromyelitis optica

Jarius, Sven, Paul, Friedemann, Weinshenker, Brian G., Levy, Michael, Kim, Ho Jin, Wildemann, Brigitte·2020·Nature Reviews Disease Primers
DOI 10.1038/s41572-020-0214-9
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41572-020-0214-9

Cites

337 of 337 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 337 references

Research works printed but not linked: 38

  1. Jarius, S. & Wildemann, B. The history of neuromyelitis optica. J. Neuroinflammation 10, 8 (2013).
  2. Miyamoto, K. Epidemiology of multiple sclerosis and neuromyelitis optica [Japanese]. Nihon Rinsho 72, 1903–1907 (2014).
  3. Quek, A. M. et al. Effects of age and sex on aquaporin-4 autoimmunity. Arch. Neurol. 69, 1039–1043 (2012).
  4. Blanco, Y. et al. HLA-DRB1 typing in Caucasians patients with neuromyelitis optica [Spanish]. Rev. Neurol. 53, 146–152 (2011).
  5. Pandit, L., Malli, C., D’Cunha, A. & Mustafa, S. Human leukocyte antigen association with neuromyelitis optica in a south Indian population. Mult. Scler. 21, 1217–1218 (2015). · doi:10.1177/1352458515574149
  6. Varela, F. et al. Smoking and disease severity in patients with neuromyelitis optica (P6.162). Neurology 86 (Suppl. 16), P6.162 (2016). · doi:10.1212/wnl.86.16_supplement.p6.162
  7. Rao, A., Raoand, H. & Shah, R. Tobacco abuse worsening outcome in neuromyelitis optica. J. Neurol. Dis. 6, 56 (2018).
  8. Kremer, L. et al. Tobacco smoking and severity of neuromyelitis optica (S46.002). Neurology 84 (Suppl. 14), S46.002 (2015). · doi:10.1212/wnl.84.14_supplement.s46.002
  9. Eskandarieh, S., Moghadasi, A. N., Sahraiain, M. A., Azimi, A. R. & Molazadeh, N. Association of cigarette smoking with neuromyelitis optica-immunoglobulin G sero-positivity in neuromyelitis optica spectrum disorder. Iran. J. Neurol. 18, 93–98 (2019).
  10. Tuzun, E., Kucukhuseyin, O., Kurtuncu, M., Turkoglu, R. & Yaylim, I. Reduced serum vitamin D levels in neuromyelitis optica. Neurol. Sci. 36, 1701–1702 (2015). · doi:10.1007/s10072-015-2229-7
  11. Jitprapaikulsan, J., Siritho, S. & Prayoonwiwat, N. Vitamin D level status in Thai neuromyelitis optica patients. J. Neuroimmunol. 295–296, 75–78 (2016). · doi:10.1016/j.jneuroim.2016.03.016
  12. Shan, Y. et al. Serum 25-hydroxyvitamin D3 is associated with disease status in patients with neuromyelitis optica spectrum disorders in south China. J. Neuroimmunol. 299, 118–123 (2016). · doi:10.1016/j.jneuroim.2016.09.006
  13. Gao, M. et al. Low levels of vitamin D and the relationship between vitamin D and Th2 axis-related cytokines in neuromyelitis optica spectrum disorders. J. Clin. Neurosci. 61, 22–27 (2019). · doi:10.1016/j.jocn.2018.11.024
  14. von Budingen, H. C. et al. The myelin oligodendrocyte glycoprotein directly binds nerve growth factor to modulate central axon circuitry. J. Cell Biol. 210, 891–898 (2015). · doi:10.1083/jcb.201504106
  15. Lucchinetti, C. et al. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann. Neurol. 47, 707–717 (2000). · DOI
  16. Nakajima, H. et al. Visual field defects of optic neuritis in neuromyelitis optica compared with multiple sclerosis. BMC Neurol. 10, 45 (2010). · doi:10.1186/1471-2377-10-45
  17. Etemadifar, M. et al. Prevalence of Lhermitte’s sign in multiple sclerosis versus neuromyelitis optica. Iran. J. Neurol. 13, 50–51 (2014).
  18. Shen, C. H. et al. Seizure occurrence in myelin oligodendrocyte glycoprotein antibody-associated disease: a systematic review and meta-analysis. Mult. Scler. Relat. Disord. 42, 102057 (2020). · doi:10.1016/j.msard.2020.102057
  19. Elsone, L., Goh, Y. Y., Trafford, R., Mutch, K. & Jacob, A. How often does respiratory failure occur in neuromyelitis optica? J. Neurol. Neurosurg. Psychiatry 84, e2 (2013). · doi:10.1136/jnnp-2013-306573.175
  20. Kim, S. M., Go, M. J., Sung, J. J., Park, K. S. & Lee, K. W. Painful tonic spasm in neuromyelitis optica: incidence, diagnostic utility, and clinical characteristics. Arch. Neurol. 69, 1026–1031 (2012).
  21. Budhram, A. et al. Unilateral cortical FLAIR-hyperintense lesions in anti-MOG-associated encephalitis with seizures (FLAMES): characterization of a distinct clinico-radiographic syndrome. J. Neurol. 266, 2481–2487 (2019). · doi:10.1007/s00415-019-09440-8
  22. Budhram, A., Sechi, E., Nguyen, A., Lopez-Chiriboga, A. S. & Flanagan, E. P. FLAIR-hyperintense lesions in anti-MOG-associated encephalitis with seizures (FLAMES): is immunotherapy always needed to put out the fire? Mult. Scler. Relat. Disord. 44, 102283 (2020). · doi:10.1016/j.msard.2020.102283
  23. Jarius, S. et al. Intrathecal polyspecific immune response against neurotropic viruses discriminates between multiple sclerosis and acute demyelinating encephalomyelitis. J. Neurol. 253, P486 (2006).
  24. Bonnan, M. & Cabre, P. Plasma exchange in severe attacks of neuromyelitis optica. Mult. Scler. Int. 2012, 787630 (2012).
  25. Mealy, M. A. & Levy, M. Favorable outcome of granulocyte colony-stimulating factor use in neuromyelitis optica patients presenting with agranulocytosis in the setting of rituximab. J. Neuroimmunol. 287, 29–30 (2015). · doi:10.1016/j.jneuroim.2015.08.003
  26. Novi, G. et al. Tocilizumab in MOG-antibody spectrum disorder: a case report. Mult. Scler. Relat. Disord. 27, 312–314 (2019). · doi:10.1016/j.msard.2018.11.012
  27. Paul, F., Dorr, J., Wurfel, J., Vogel, H. P. & Zipp, F. Early mitoxantrone-induced cardiotoxicity in secondary progressive multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 78, 198–200 (2007). · doi:10.1136/jnnp.2006.091033
  28. Ramanathan, R. S., Malhotra, K. & Scott, T. Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate. BMC Neurol. 14, 51 (2014). · doi:10.1186/1471-2377-14-51
  29. Minagar, A. & Sheremata, W. A. Treatment of Devic’s disease with methotrexate and prednisone. Int. J. MS Care 2, 39–43 (2000).
  30. Iida, S., Nakamura, M., Wate, R., Kaneko, S. & Kusaka, H. Successful treatment of paroxysmal tonic spasms with topiramate in a patient with neuromyelitis optica. Mult. Scler. Relat. Disord. 4, 457–459 (2015). · doi:10.1016/j.msard.2015.07.011
  31. Usmani, N., Bedi, G., Lam, B. L. & Sheremata, W. A. Association between paroxysmal tonic spasms and neuromyelitis optica. Arch. Neurol. 69, 121–124 (2012). · doi:10.1001/archneurol.2011.832
  32. Schwartz, K. et al. Randomized, placebo-controlled crossover study of dalfampridine extended-release in transverse myelitis. Mult. Scler. J. Exp. Transl. Clin. 3, 2055217317740145 (2017).
  33. Wildemann, B. et al. Failure of alemtuzumab therapy to control MOG encephalomyelitis. Neurology 89, 207–209 (2017). · doi:10.1212/wnl.0000000000004087
  34. Ringelstein, M. et al. Long-term interleukin-6-receptor blockade in neuromyelitis optica spectrum disorder and MOG associated encephalomyelitis. ECTRIMS Online Lib. 278546, P1344 (2019).
  35. Miyamoto, K. et al. Nationwide epidemiological study of neuromyelitis optica in Japan. J. Neurol. Neurosurg. Psychiatry 89, 667–668 (2018). · doi:10.1136/jnnp-2017-317321
  36. Takai, Y. et al. Perivenous inflammatory demyelination with MOG-dominant myelin loss is a characteristic feature of MOG antibody-associated disease. ECTRIMS Online Lib. 279522, 244 (2019).
  37. Sahraian, M. A., Moghadasi, A. N., Owji, M., Naghshineh, H. & Minagar, A. Neuromyelitis optica with linear enhancement of corpus callosum in brain magnetic resonance imaging with contrast: a case report. J. Med. Case Rep. 9, 137 (2015). · doi:10.1186/s13256-015-0613-9
  38. Reuss, R. et al. Anti-AQP4 AB Might be Relevant in Pregnancy. BMJ http://www.bmj.com/rapid-response/2011/11/02/anti-aqp4-ab-might-be-relevant-pregnancy (2010).

Cited by

See all 478

Metadata

Authors
Jarius, S., Paul, F., Weinshenker, B. G., Levy, M., Kim, H. J., & Wildemann, B.
Venue
Nature Reviews Disease Primers
Publisher
Springer Science and Business Media LLC
Published
2020-10-22
Volume
6
Issue
1
Pages
85-85
ISSN
2056-676X (ISSN-L)
DOI
10.1038/s41572-020-0214-9
OpenAlex
W4206710086
Cited by
478
References
337
FWCI
13.78
Type
journal article
Language
en
Open access
closed
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Neuromyelitis optica. https://app.cochat.ai/papers/10.1038/s41572-020-0214-9
The paper
Jarius, S., Paul, F., Weinshenker, B. G., Levy, M., Kim, H. J., & Wildemann, B. (2020). Neuromyelitis optica. Nature Reviews Disease Primers. https://doi.org/10.1038/s41572-020-0214-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.